A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorRenJi Hospital
About this trial
The goal of this observational study is to draw the characteristic maps of imaging omics, genomics, transcriptome, proteomics, pathological omics, metabolomics, etc. of the dynamic evolution of endometrial carcinogenesis in 100 patients with normal endometrium, 100 patients with atypical endometrial hyperplasia, and 100 patients with endometrial cancer; and then to explore the underlying molecular mechanism, and establish the database system for the dynamic evolution of endometrial carcinogenesis.
Eligibility criteria
Qualifiers
Pathological diagnosis: normal endometrium, atypical hyperplasia endometrium, or endometrial cancer;
Obtain pathological results after undergoing hysteroscopic surgery or hysterectomy;
The patient voluntarily participated in this research project with good compliance and was able to complete the enrollment according to the experimental requirements;
Sign the informed consent form and consent to the collection and use of their data, and consent to genomics, transcriptome and other tests.
Disqualifiers
Patients with malignant tumors in other parts of the body;
Suffering from uncontrollable neurological diseases, psychiatric diseases, or psychiatric disorders;
Poor compliance and inability to cooperate and describe treatment responders.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 3 trial groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov